Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19

Circulation. 2020 Nov 10;142(19):1878-1880. doi: 10.1161/CIRCULATIONAHA.120.050089. Epub 2020 Sep 10.

Torbjørn Omland^{1

2}, Christian Prebensen^{3

2}, Ragnhild Røysland^{4

2}, Signe Søvik^{5

2}, Vibecke Sørensen⁵, Helge Røsjø^{6

2}, My Svensson^{1

2}, Jan Erik Berdal^{3

2}, Peder L Myhre^{1

2}

¹ Department of Cardiology (T.O., P.L.M.), Akershus University Hospital, Lørenskog, Norway.
² Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway (T.O., C.P., R.R., S.S., H.R., M.S., J.E.B., P.L.M.).
³ Department of Infectious Diseases (C.P., J.E.B.), Akershus University Hospital, Lørenskog, Norway.
⁴ Department of Division of Medicine, Multidisciplinary Laboratory Medicine and Medical Biochemistry, Division of Diagnostics and Technology (R.R.), Akershus University Hospital, Lørenskog, Norway.
⁵ Department of Anaesthesia and Intensive Care, Division of Surgery (S.S., V.S.), Akershus University Hospital, Lørenskog, Norway.
⁶ Division of Research and Innovation (H.R.), Akershus University Hospital, Lørenskog, Norway.

No abstract available

Keywords: COVID-19; biomarkers; cardiovascular diseases; mortality; prognosis.

Publication types